OMERS ADMINISTRATION Corp bought a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 4,000 shares of the biopharmaceutical company’s stock, valued at approximately $708,000. Other hedge funds and other institutional investors also recently added […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Rating Reiterated by Royal Bank of Canada themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They currently have a $200.00 price objective on the biopharmaceutical company’s stock. Needham & Company LLC’s price target points to a potential upside of 36.05% from the […]
Massachusetts Financial Services Co. MA increased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 688,228 shares of the biopharmaceutical company’s stock after acquiring an additional 15,831 shares […]
Privium Fund Management B.V. acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 20,023 shares of the biopharmaceutical company’s stock, valued at approximately $3,546,000. Alnylam Pharmaceuticals accounts for about 1.1% of Privium Fund Management B.V.’s holdings, making the stock its […]